O'Shaughnessy Laura 4

What Happened Laura O'Shaughnessy, a director of Acuity, received a grant of 546 deferred restricted stock units (DSUs) on 2026-01-21. The DSUs were issued as an award (derivative acquisition) at $0.00 cash price; the filing values the award at about $320.59 per share, or roughly $175,042 in total. This was an award tied to director compensation (an election to receive fees in DSUs), not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-01-21; Form 4 filed 2026-01-23 (appears timely, within typical two-business-day reporting window).
• Instrument: 546 Deferred Restricted Stock Units (DSUs); acquisition coded as A (award/other acquisition) and reported as derivative.
• Reported per-share valuation: $320.59 (average of the high and low sales prices over the five trading days before the grant); total value ≈ $175,042.14.
• Vesting/payment: DSUs vest in full on the first anniversary of the grant date or, if earlier, the next annual stockholder meeting. Once vested, payment is made upon retirement either in a lump sum or in five annual installments (see footnote F2).
• One-for-one conversion: Each DSU converts 1-for-1 to a share upon settlement (footnote F1).
• Shares owned after transaction: Not specified in the filing.
• Footnotes: F2 explains these are DSUs elected in lieu of director fees; F3 explains the $320.59 pricing method.

Context DSUs are deferred-compensation awards, not immediate open-market purchases or sales, so they generally reflect compensation elections rather than a direct trading signal. The grant resulted from a routine director election to receive fees in DSUs and will only convert to cash or stock upon vesting/retirement under the plan terms.